Clovis Oncology (CLVS) Misses Q3 EPS by 55c

Clovis Oncology (NASDAQ: CLVS) reported Q3 EPS of ($2.62), $0.55 worse than the analyst estimate of ($2.07).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BofA maintains underperform ratings on six BDC stocks
• Ross Stores, Inc. (ROST) PT Raised to $240 at Bernstein SocGen Group